WARRENDALE, Pa., Oct. 2 /PRNewswire/ -- MEDRAD's Heilman Center electro-mechanical manufacturing plant located in Fox Chapel, Pa. has been selected as a 2007 IndustryWeek magazine "Best Plant Finalist." This award is issued annually to plants that are on the leading edge of efforts to increase competitiveness, enhance customer satisfaction, and create stimulating and rewarding work environments.
MEDRAD's Heilman Center plant was one of approximately twenty-five finalists selected from close to 200 applicant companies. Ten North American winners will be announced in the January 2008 issue of IndustryWeek.
MEDRAD's Heilman Center Plant manufactures electronic fluid delivery systems that enhance cardiovascular (CV), Computerized Tomography (CT) and Magnetic Resonance (MR) diagnostic scans, and MR coils and accessories used in medical imaging. The plant opened in 2002 and currently operates one shift of 176 employees working five days per week. Significant achievements include launch of a lean manufacturing system that has reduced assembly errors and training time by 35 percent, increased output per employee by 20% and increased overall productivity 30 percent. The plant also converted to cellular manufacturing, and moved to an inventory "demand pull" replenishment technique program, resulting in a total inventory savings to date of $1 million.
IndustryWeek magazine, a market-leading publication serving the manufacturing industry, selects the finalists from applications which report management practices and plant performance in such areas as quality, customer and supplier relations, employee involvement, application of new technologies, productivity, cost reductions, manufacturing flexibility and responsiveness, inventory management, environmental and safety performance, new product development and overall market results. Manufacturing facilities in the United States, Canada and Mexico are eligible.
"The Heilman Center plant next moves to the final step in the award process, which includes answering a more detailed questionnaire focused on specific plant achievements and process improvements, and possibly a site visit," explains Mike Kochis, Heilman Center plant manager and coordinator of MEDRAD's application process.
Recent award recipients include Boeing, Siemens AG, Guidant, Boston Scientific, Kennametal, IBM, General Electric and Dell Computer. Prior winners from the Pittsburgh area include manufacturing plants from MSA's Safety Products Division in Murrysville (2000), General Cable Automotive Products in Altoona (2003) and Magee Rieger Automotive Systems in Bloomsburg (2006).
MEDRAD, INC. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2006 revenues were $478 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG. More company information is available at http://www.medrad.com.
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at http://www.bayerhealthcare.com.
Cautionary statement regarding forward-looking statements.
Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD, INC. undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.
Copyright©2007 PR Newswire.
All rights reserved